Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease, which is characterized by progressive, persistent airflow limitation with an enhanced chronic inflammatory response in the airway to noxious particles. 1 Chronic Obstructive Pulmonary Disease (COPD) is the fourth common cause of death in the whole world. COPD is a major cause of chronic morbidity and mortality throughout the world with big economic and social burden. 2, 3 COPD burden is increasing day by day because of continuous exposure to its risk factors. Often, the prevalence of COPD is directly related to the prevalence of tobacco smoking. 3, 4 COPD prevalence data show some variations in different parts of the worlds due to differences in survey methods, analytical approaches and exposure to different types of risk factors. Most national data show that less than 6% of the adult population has been suffering in COPD. 5 A systematic review and metaanalysis of studies carried out in 28 countries between 1990 to 2004 showed that the prevalence is higher in smokers and ex-smokers over 40 years of age. Prevalence was higher in men than in women. 5 The Global Burden of Disease Study projected that COPD was ranked sixed cause of death in 1990, will become the third leading cause of death worldwide by 2020. 6 COPD is a big economic burden. In the United States the estimated direct costs of COPD are $29.5 billion and the indirect costs $20.4 billion. 7 In developing countries, direct medical costs as well as the impact on workplace and home productivity is very important.
The chronic airflow limitation of COPD is a mixture of small airways disease (obstructive bronchiolitis) and parenchymal destruction (emphysema). 1 Inhalation of cigarette smoke and other noxious particles such as smoke from biomass fuels causes modified pulmonary inflammation. These chronic inflammatory responses induce parenchymal tissue destruction (resulting in emphysema) and disrupt normal tissue repair and defense mechanisms (resulting in small airway fibrosis). 1 These pathological changes lead to air trapping and progressive airflow limitation in lung, causes breathlessness and other characteristic symptoms of COPD. 1
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